Pacemaker implantation is a cornerstone therapy in cardiovascular medicine designed to correct bradycardia (abnormally slow heart rate) and cardiac conduction defects. The primary goal is to re-establish an adequate heart rate to ensure proper blood flow and oxygenation to vital organs. The mechanism involves an implantable pulse generator connected to thin insulated wires, known as cardiac leads, which monitor intrinsic electrical activity and deliver targeted electrical stimulation whenever the heart's natural electronic timing system fails.

1. Patient positioning and sterile skin preparation in the cardiac catheterization or electrophysiology laboratory.
2. Administration of intravenous conscious sedation and local anaesthetic infiltration below the clavicle.
3. Creation of a horizontal skin incision (3-5 cm) and blunt dissection to form a subcutaneous or submuscular pocket.
4. Accessing the venous system via venous cutdown or percutaneous puncture of the cephalic, subclavian, or axillary vein.
5. Advancing the transvenous pacing leads into the right atrium, right ventricle, or left ventricular coronary sinus branch under fluoroscopic guidance.
6. Securing lead tips into the endocardium using active screw-in mechanisms or passive tined mechanisms.
7. Performing intraoperative electrical testing (sensing thresholds, pacing impedance, and capture thresholds) using a pacing system analyzer.
8. Connecting the lead pins securely into the pulse generator header.
9. Inserting the pulse generator into the pre-formed tissue pocket.
10. Closing the pocket in multiple anatomical layers using absorbable sutures and applying a sterile surgical dressing.

Evidence from major clinical trials demonstrates that permanent pacemaker implantation significantly alleviates symptoms of bradycardia, improves exercise capacity, and enhances overall quality of life. In high-grade AV block, cardiac pacing provides a clear survival benefit by preventing sudden cardiac arrest and fatal asystole (ACC/AHA/HRS 2018 Guidelines). Advanced pacing modalities, such as dual-chamber and biventricular pacing, preserve physiological atrial-ventricular synchrony, reducing the long-term risk of heart failure hospitalisation and atrial fibrillation compared to single-chamber ventricular pacing.

Immediate recovery involves four to six hours of bed rest with vital sign and continuous telemetry monitoring. Most patients are discharged within 24 hours after a device check and chest X-ray confirm stable lead placement and the absence of a pneumothorax (collapsed lung). For the first 2 to 4 weeks, patients must avoid raising the ipsilateral arm above shoulder height or lifting objects heavier than 5 kilograms to prevent lead displacement. Wound healing takes approximately 10 to 14 days. Full functional recovery and return to routine daily activities, driving, and non-strenuous work typically occur within 2 to 4 weeks, subject to clinical approval and local driving regulations.

Pacemaker implantation is primarily indicated for symptomatic bradycardia, sick sinus syndrome (sinus node dysfunction), high-grade atrioventricular block (AV block), slow ventricular response in atrial fibrillation, and symptomatic sinus pauses. It is also used in cardiac resynchronization therapy (CRT) for patients with heart failure and ventricular dyssynchrony.

1. Pre-operative clinical evaluation including physical examination, baseline blood tests (complete blood count, renal function, coagulation profile), and baseline 12-lead ECG.
2. Review and adjustment of antiplatelet and anticoagulant medications in consultation with the cardiology team according to current guidelines.
3. Fasting for 6 to 8 hours prior to the procedure, as instructed by the clinical care team.
4. Pre-procedure skin cleansing using antiseptic chlorhexidine washes to reduce surgical site infection risk.
5. Prophylactic intravenous antibiotic administration within 60 minutes prior to surgical incision.

Common/Mild:
- Localized surgical site discomfort, mild bruising, or minor hematoma formation at the pocket site.
- Mild incisional swelling.

Uncommon:
- Lead dislodgement or displacement requiring lead repositioning surgery (1-3%).
- Pocket hematoma requiring surgical evacuation or prolonged observation (1-2%).
- Superficial surgical site infection.

Rare/Serious:
- Deep device or lead infection, endocarditis, or sepsis (<1%).
- Pneumothorax or hemothorax requiring chest tube drainage (1-2%).
- Cardiac perforation or pericardial effusion with cardiac tamponade (<1%).
- Venous thrombosis of the subclavian or axillary vein.
- Pocket erosion through the skin.

The clinical journey begins with a comprehensive cardiovascular evaluation, including an electrocardiogram (ECG), ambulatory telemetry monitoring, and an echocardiogram. On the day of the procedure, local anaesthesia and conscious sedation are administered. The cardiologist creates a small subcutaneous pocket beneath the collarbone, threads the cardiac leads through a vein into the heart under fluoroscopic guidance, and connects them to the pulse generator. Following implantation, patients undergo monitoring, lead interrogation, and a post-procedure chest X-ray. Short-term recovery requires limiting upper limb movement for two to four weeks, followed by long-term device monitoring every 3 to 12 months.